Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML)

Clinical trial NCT01736683 · COMPLETED

Trial details

NCT number: NCT01736683
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anemia Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia Low to Intermediate-1 MDS Myelodysplastic Syndromes (MDS)Chronic Myelomonocytic Leukemia (CMML)

Start date: 2012-11-28
Primary completion: 2018-04-30
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.